Literature DB >> 15501014

Immunomodulating effect of influenza vaccination in the elderly differing in health status.

J Myśliwska1, P Trzonkowski, E Szmit, L B Brydak, M Machała, A Myśliwski.   

Abstract

The aim of this study was to analyse whether split influenza vaccine may elicit NK cytotoxic response in the vaccinated elderly people and whether this effect may be maintained over few weeks after vaccination. It was also worth investigating the relation between NK activity in the vaccinated and specific immune protection against influenza and non-specific against other infections. Two groups of volunteers were vaccinated with trivalent split viron influenza vaccine in two consecutive seasons (1999/2000; 2000/2001). The elderly group consisted of 142 people (65-92 years old) in the first season and 110 in the second; while the young (16-44 years old) of 98 and 67 people, respectively. An analysis of NK cytotoxic activity had been done before vaccination, two days, one month and fifth months thereafter. The results revealed that vaccination with the influenza vaccine had an augmenting effect on NK activity, in all groups examined, in both epidemic seasons, visible at two days and 1 month after the vaccination. In the elderly high pre- and post-vaccination NK activity was related to higher titers of anti-hemagglutinin, better health status and lower incidence of all cause respiratory tract infections. At the second vaccination, most of the elderly with chronic medical conditions and high NK activity, who did not attain the protective level of anti-hemagglutinins in the first season, converted into the protected. High pre- and post-vaccination NK activity predisposes elderly people to the protective humoral anti-hemagglutinin response and gives better protection from respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501014     DOI: 10.1016/j.exger.2004.08.005

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  26 in total

1.  Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

Authors:  Xiao-Song He; Tyson H Holmes; Caiqiu Zhang; Kutubuddin Mahmood; George W Kemble; David B Lewis; Cornelia L Dekker; Harry B Greenberg; Ann M Arvin
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 2.  Factors affecting immune responses to the influenza vaccine.

Authors:  Maria R Castrucci
Journal:  Hum Vaccin Immunother       Date:  2017-07-21       Impact factor: 3.452

3.  Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.

Authors:  Mary S Hayney; Christopher L Coe; Daniel Muller; Chidi N Obasi; Uba Backonja; Tola Ewers; Bruce Barrett
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

4.  Factors that may impact on immunosenescence: an appraisal.

Authors:  Joseph Ongrádi; Valéria Kövesdi
Journal:  Immun Ageing       Date:  2010-06-14       Impact factor: 6.400

Review 5.  Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach.

Authors:  Nathaniel D Lambert; Inna G Ovsyannikova; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

6.  Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons.

Authors:  Amir Tajbakhsh; Khojaste Rahimi Jaberi; Seyed Mohammad Gheibi Hayat; Mehrdad Sharifi; Thomas P Johnston; Paul C Guest; Mohammad Jafari; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Vaccination in the elderly: an immunological perspective.

Authors:  Wilbur H Chen; Bernard F Kozlovsky; Rita B Effros; Beatrix Grubeck-Loebenstein; Robert Edelman; Marcelo B Sztein
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

8.  The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.

Authors:  Bohdan Nosyk; Behnam Sharif; Huiying Sun; Curtis Cooper; Aslam H Anis
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

9.  NK cell compartment in patients with coronary heart disease.

Authors:  Łukasz Hak; Jolanta Myśliwska; Joanna Więckiewicz; Krzysztof Szyndler; Piotr Trzonkowski; Janusz Siebert; Andrzej Myśliwski
Journal:  Immun Ageing       Date:  2007-05-08       Impact factor: 6.400

10.  Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.

Authors:  Xiao-Song He; Tyson H Holmes; Sanae Sasaki; Maria C Jaimes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Harry B Greenberg
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.